Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-144275
Filing Date
2013-04-05
Accepted
2013-04-05 17:21:00
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d444046d10k.htm 10-K 860666
2 EXHIBIT 21 d444046dex211.htm EX-21.1 2943
3 EXHIBIT 23.1 d444046dex231.htm EX-23.1 2183
4 EXHIBIT 31.1 d444046dex311.htm EX-31.1 6263
5 EXHIBIT 31.2 d444046dex312.htm EX-31.2 6241
6 EXHIBIT 32 d444046dex32.htm EX-32 3816
  Complete submission text file 0001193125-13-144275.txt   8252622

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cxm-20121231.xml EX-101.INS 947347
8 XBRL TAXONOMY EXTENSION SCHEMA cxm-20121231.xsd EX-101.SCH 89975
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cxm-20121231_cal.xml EX-101.CAL 94860
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cxm-20121231_def.xml EX-101.DEF 323816
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cxm-20121231_lab.xml EX-101.LAB 651800
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cxm-20121231_pre.xml EX-101.PRE 474283
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33635 | Film No.: 13746737
SIC: 2836 Biological Products, (No Diagnostic Substances)